Form 4 for GILD Gilead Sciences
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001127602-22-008127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-03 | 2022-03-01 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +54.3K | 259.6K | +26% | — |
| D | 2022-03-03 | 2022-03-01 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $60.26 | -23.2K | 236.4K | -9% | -$1.40M |
| DM | 2022-03-03 | 2022-03-01 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | -54.3K | 96.6K | -36% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | M | A | 11,362 | — | 216,716 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2022-03-01 | M | A | 42,922 | — | 259,638 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 3 | Common | Common Stock | 2022-03-01 | F | D | 23,245 | $60.26 | 236,393 | D | — | — | |
| 4 | Derivative | Restricted Stock Unit | 2022-03-01 | M | D | 11,362 | — | 139,494 | D | — · — to — | 11,362 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. |
| 5 | Derivative | Restricted Stock Unit | 2022-03-01 | M | D | 42,922 | — | 96,572 | D | — · — to — | 42,922 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a three year vesting schedule. 1/3 vest on each yearly anniversary of the date of grant until fully vested. |